Butein suppresses hepatocellular carcinoma growth via modulating Aurora B kinase activity

about

Butein suppresses hepatocellular carcinoma growth via modulating Aurora B kinase activity

Item

http://www.wikidata.org/entity/Q58758540

description

im Jahr 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Butein suppresses hepatocellular carcinoma growth via modulating Aurora B kinase activity

@en

Butein suppresses hepatocellular carcinoma growth via modulating Aurora B kinase activity

@nl

type

Item

label

Butein suppresses hepatocellular carcinoma growth via modulating Aurora B kinase activity

@en

Butein suppresses hepatocellular carcinoma growth via modulating Aurora B kinase activity

@nl

prefLabel

Butein suppresses hepatocellular carcinoma growth via modulating Aurora B kinase activity

@en

Butein suppresses hepatocellular carcinoma growth via modulating Aurora B kinase activity

@nl

P1476

Butein suppresses hepatocellular carcinoma growth via modulating Aurora B kinase activity

@en

P2093

Feng Gao

http://www.w3.org/2001/XMLSchema#string

Li Zhou

http://www.w3.org/2001/XMLSchema#string

Ming Li

http://www.w3.org/2001/XMLSchema#string

Tian Li

http://www.w3.org/2001/XMLSchema#string

Ting Liu

http://www.w3.org/2001/XMLSchema#string

Wei Li

http://www.w3.org/2001/XMLSchema#string

Wenbin Liu

http://www.w3.org/2001/XMLSchema#string

Xinyou Yu

http://www.w3.org/2001/XMLSchema#string

Yuanfeng Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

ANCHR mediates Aurora-B-dependent abscission checkpoint control through retention of VPS4

Aurora-A Kinase as a Promising Therapeutic Target in Cancer

First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway

Sorafenib in advanced hepatocellular carcinoma

Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC.

Deguelin inhibits non-small cell lung cancer via down-regulating Hexokinases II-mediated glycolysis.

Butein suppresses breast cancer growth by reducing a production of intracellular reactive oxygen species

Integrating traditional medicine into modern inflammatory diseases care: multitargeting by Rhus verniciflua Stokes

Stage I of a phase 2 study assessing the efficacy, safety, and tolerability of barasertib (AZD1152) versus low-dose cytosine arabinoside in elderly patients with acute myeloid leukemia.

The aurora kinases in cell cycle and leukemia

P304

1521-1534

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/IJBS.25334

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30263005

http://www.w3.org/2001/XMLSchema#string

P921

molecular biology

P932

6158728

http://www.w3.org/2001/XMLSchema#string